36 Participants Needed

School Readiness Program for Sickle Cell Disease

AH
Overseen ByANDREW HEITZER, PhD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: St. Jude Children's Research Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a program designed to prepare young children with sickle cell disease for school. The main goal is to determine if the adapted Kids in Transition to School Intervention is practical and well-received by children aged 3.5 to 6.5 years with sickle cell disease. Researchers will also compare the program's effectiveness to regular school resources and identify any challenges in its implementation. Participants include English-speaking children with sickle cell disease enrolled in a specific research program, along with a willing caregiver. As an unphased trial, this study allows participants to contribute to innovative educational support strategies for young children with sickle cell disease.

Do I need to stop my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on a school readiness program, so it's unlikely that medication changes are required, but you should confirm with the trial coordinators.

What prior data suggests that this school readiness program is safe for children with sickle cell disease?

Research shows that the adapted Kids in Transition to School Intervention helps children with sickle cell disease prepare for school. An initial trial involved 24 children with sickle cell anemia in a similar school program. This program significantly improved their understanding of their condition without causing any negative effects.

While specific safety data for this exact program is unavailable, it focuses on educational support, suggesting it is likely safe. Similar educational programs have generally been safe, as they primarily involve learning activities and include caregivers. Any major safety issues would likely have been identified in earlier studies.12345

Why are researchers excited about this trial?

Researchers are excited about the School Readiness Program for Sickle Cell Disease because it offers a novel approach to supporting children with this condition as they prepare for school. Unlike standard resources that simply provide information and books, this program involves interactive virtual classroom sessions where caregivers and children engage with educators and social workers. This personalized and immersive method aims to enhance school readiness skills, such as early math and reading, while also strengthening parent-child relationships. By focusing on these developmental areas, the program hopes to give children with sickle cell disease a better start in their educational journey.

What evidence suggests that the adapted Kids in Transition to School Intervention is effective for school readiness in children with sickle cell disease?

Research has shown that the Kids in Transition to School (KITS) Program could benefit children with sickle cell disease. In this trial, participants in the school readiness group will receive the adapted KITS Intervention. Previous studies have found that similar school programs can greatly improve children's understanding of their condition. Another study on children with developmental and behavior issues found that KITS helped them prepare for school by boosting early math and reading skills. These findings suggest that using KITS for children with sickle cell disease might enhance their school readiness by focusing on key learning and development areas. This targeted support may help children manage both their school and health challenges more effectively.12367

Who Is on the Research Team?

AH

ANDREW Heitzer, PhD

Principal Investigator

St. Jude Children's Research Hospital

Are You a Good Fit for This Trial?

This trial is for preschool children aged 4-6 with sickle cell disease, or their caregivers. It aims to test a school readiness program specifically adapted for these children. Participants should be ready to engage in the study's activities and assessments.

Inclusion Criteria

Enrolled on the institutional protocol: Sickle Cell Clinical Research Intervention Program (SCCRIP)
I am between 4 and 6 years old.
English as the primary language
See 4 more

Exclusion Criteria

Non-English speakers
Do not have a child diagnosed with SCD of any genotype between the ages of 4.0-6.0 years and enrolled in SCCRIP

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants attend virtual classroom program sessions for school readiness, including caregiver interviews and assessments

8 weeks
8 virtual sessions

Follow-up

Participants are monitored for school readiness skills and caregiver satisfaction after the intervention

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • The adapted Kids in Transition to School Intervention
Trial Overview The trial is testing an adapted Kids in Transition to School Intervention against standard school resources provided to young children with sickle cell disease. The goal is to assess how feasible and acceptable this tailored intervention is.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Readiness InterventionExperimental Treatment1 Intervention
Group II: Control: Standard school resourcesExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

St. Jude Children's Research Hospital

Lead Sponsor

Trials
451
Recruited
5,326,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Published Research Related to This Trial

The review analyzed 27 studies on behavioral interventions for children with sickle cell disease, highlighting the effectiveness of education on disease knowledge, self-management, and pain management, particularly for older children (5+ years).
There is a significant gap in research for interventions aimed at younger children (0-3 years), indicating a need for future studies to explore how to support this age group and understand the developmental impacts of sickle cell disease.
Individual-level behavioral interventions to support optimal development of children with sickle cell disease: A systematic review.Hoyt, CR., Hurwitz, S., Varughese, TE., et al.[2023]
In a study of 316 children with sickle cell disease (SCD), the presence of a dedicated Education Liaison (EL) significantly increased the likelihood of children receiving neuropsychological testing (NPT) and educational accommodations, such as Individualized Education Programs (IEPs) and Section 504 plans.
After the intervention, the percentage of children with accommodations rose from 52.8% to 64.6%, demonstrating that integrating an EL into the SCD care team can effectively enhance access to necessary educational support for these children.
Education Liaison improves implementation of school accommodations for students with sickle cell disease.McGlynn, MC., Gilliam, A., Pierson, SK., et al.[2023]
The Sickle Cell Transition E-Learning Program (STEP) had a participation rate of only 29% among 183 youths with sickle cell disease, indicating a need for improved engagement strategies.
Completing more modules of STEP was positively correlated with increased disease knowledge, particularly for those who completed three or more modules, which is crucial for self-management during the transition to adult care.
Web-Based Technology to Improve Disease Knowledge Among Adolescents With Sickle Cell Disease: Pilot Study.Saulsberry, AC., Hodges, JR., Cole, A., et al.[2020]

Citations

School Readiness Intervention for Preschool Children With ...This study is being done to test a school readiness program for children with sickle cell disease (ages 3.5-6,5 years old). Primary Objective. Assess ...
Project Details - NIH RePORTERThis will be the first study to adapt and test an intervention approach fitted for patients with SCD, facilitating the development of targeted interventions ...
School Readiness Program for Sickle Cell DiseaseA pilot trial involving 24 children with sickle cell anemia showed that a school intervention program (SIP) significantly improved disease knowledge among both ...
SKITS2: School Readiness Intervention for Sickle Cell ...This study will test a school readiness program that St. Jude made for caregivers or parents of young children with sickle cell disease. This program is the ...
Efficacy Trial of the Kids in Transition to School (KITS) ...This study focuses on children entering kindergarten with co-occurring developmental disabilities and behavior problems, a population especially likely to ...
Improving Health Care Transition for Young Patients With ...In this quality improvement study of 458 pediatric patients with sickle cell disease, 5 hematology centers successfully implemented health care transition ...
Sickle Cell Trevor Thompson Transition Project (ST3P-UP) ...Due to early diagnosis, innovative preventative therapies, and improved comprehensive care, over 95% of children with SCD will survive into adulthood [4]. While ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security